Literature DB >> 29026591

Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practice.

Paul Moayyedi1, Fermín Mearin2, Fernando Azpiroz3, Viola Andresen4, Giovanni Barbara5, Maura Corsetti6, Anton Emmanuel7, A Pali S Hungin8, Peter Layer4, Vincenzo Stanghellini5, Peter Whorwell9, Frank Zerbib10, Jan Tack11.   

Abstract

BACKGROUND: Effective management of irritable bowel syndrome (IBS), a common functional gastrointestinal disorder, can be challenging for physicians because of the lack of simple diagnostic tests and the wide variety of treatment approaches available.
OBJECTIVE: The objective of this article is to outline a simple algorithm for day-to-day clinical practice to help physicians navigate key stages to reaching a positive IBS diagnosis and guidance on how to prioritise the use of specific management strategies.
METHODS: This algorithm was based on the opinion of an expert panel evaluating current evidence.
RESULTS: The key principles forming the foundation of this evidence-supported algorithm are: confidently naming and explaining an IBS diagnosis for the patient, followed by assessment of key patient characteristics likely to influence the choice of therapy, such as predominant symptoms, and exploring the patient agenda and preferences. Consultation should always include education and reassurance with an explanatory model of IBS tailored to the patient. Individualised lifestyle changes, dietary modifications, pharmacological therapies, psychological strategies or a combination of interventions may be used to optimise treatment for each patient.
CONCLUSION: The simple visual tools developed here navigate the key stages to reaching a positive diagnosis of IBS, and provide a stepwise approach to patient-centred management targeted towards the most bothersome symptoms. Establishing a strong patient-physician relationship is central to all stages of the patient journey from diagnosis to effective management.

Entities:  

Keywords:  Irritable bowel syndrome; diagnosis; management; treatment

Year:  2017        PMID: 29026591      PMCID: PMC5625880          DOI: 10.1177/2050640617731968

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  63 in total

1.  Randomized clinical trial: macrogol/PEG 3350 plus electrolytes for treatment of patients with constipation associated with irritable bowel syndrome.

Authors:  R W Chapman; V Stanghellini; M Geraint; M Halphen
Journal:  Am J Gastroenterol       Date:  2013-07-09       Impact factor: 10.864

2.  A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.

Authors:  Emma P Halmos; Victoria A Power; Susan J Shepherd; Peter R Gibson; Jane G Muir
Journal:  Gastroenterology       Date:  2013-09-25       Impact factor: 22.682

3.  Intervention to increase physical activity in irritable bowel syndrome shows long-term positive effects.

Authors:  Elisabet Johannesson; Gisela Ringström; Hasse Abrahamsson; Riadh Sadik
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

Review 4.  Post-infectious IBS, tropical sprue and small intestinal bacterial overgrowth: the missing link.

Authors:  Uday C Ghoshal; Kok-Ann Gwee
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-05-17       Impact factor: 46.802

Review 5.  The Science, Evidence, and Practice of Dietary Interventions in Irritable Bowel Syndrome.

Authors:  Brian E Lacy
Journal:  Clin Gastroenterol Hepatol       Date:  2015-03-10       Impact factor: 11.382

6.  Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.

Authors:  Anthony Lembo; Mark Pimentel; Satish S Rao; Philip Schoenfeld; Brooks Cash; Leonard B Weinstock; Craig Paterson; Enoch Bortey; William P Forbes
Journal:  Gastroenterology       Date:  2016-08-13       Impact factor: 22.682

7.  Microscopic colitis or functional bowel disease with diarrhea: a French prospective multicenter study.

Authors:  Gilles Macaigne; Pierre Lahmek; Christophe Locher; Bruno Lesgourgues; Laurent Costes; Max Pierre Nicolas; Anne Courillon-Mallet; Jean-Michel Ghilain; Guy Bellaïche; Stéphanie de Montigny-Lehnardt; Georges Barjonet; René-Louis Vitte; Roger Faroux; Benedicte Lambare; Antoine Fleury; Alexandre Pariente; Stéphane Nahon
Journal:  Am J Gastroenterol       Date:  2014-07-08       Impact factor: 10.864

8.  Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints.

Authors:  E M M Quigley; J Tack; W D Chey; S S Rao; J Fortea; M Falques; C Diaz; S J Shiff; M G Currie; J M Johnston
Journal:  Aliment Pharmacol Ther       Date:  2012-11-01       Impact factor: 8.171

Review 9.  Practical management of irritable bowel syndrome: a clinical review.

Authors:  Ellinor Almquist; Hans Törnblom; Magnus Simrén
Journal:  Minerva Gastroenterol Dietol       Date:  2015-10-08

Review 10.  Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date.

Authors:  Wathsala S Nanayakkara; Paula Ml Skidmore; Leigh O'Brien; Tim J Wilkinson; Richard B Gearry
Journal:  Clin Exp Gastroenterol       Date:  2016-06-17
View more
  37 in total

1.  Efficacy of Saccharomyces cerevisiae CNCM I-3856 as an add-on therapy for irritable bowel syndrome.

Authors:  Ravichandran Gayathri; Thangavelu Aruna; Sivaraman Malar; Bennur Shilpa; Karukkupalayam Ramasamy Dhanasekar
Journal:  Int J Colorectal Dis       Date:  2019-12-05       Impact factor: 2.571

Review 2.  Evidence-based and mechanistic insights into exclusion diets for IBS.

Authors:  Paul Moayyedi; Magnus Simrén; Premysl Bercik
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-03-02       Impact factor: 46.802

3.  Prevalence and impact of self-reported irritable bowel symptoms in the general population.

Authors:  K Van den Houte; F Carbone; J Pannemans; M Corsetti; B Fischler; H Piessevaux; J Tack
Journal:  United European Gastroenterol J       Date:  2018-12-22       Impact factor: 4.623

4.  New mint on the block - Fresh hope for IBS treatment?

Authors:  Radislav Nakov; Henriette Heinrich
Journal:  United European Gastroenterol J       Date:  2021-11-03       Impact factor: 4.623

Review 5.  Physical activity for treatment of irritable bowel syndrome.

Authors:  David Nunan; Ting Cai; Antoni D Gardener; José M Ordóñez-Mena; Nia W Roberts; Elizabeth T Thomas; Kamal R Mahtani
Journal:  Cochrane Database Syst Rev       Date:  2022-06-29

6.  Functional Abdominal Cramping Pain: Expert Practical Guidance.

Authors:  Stefan Müller-Lissner; Viola Andresen; Maura Corsetti; Luis Bustos Fernández; Sylvie Forestier; Fabio Pace; Miguel A Valdovinos
Journal:  J Clin Gastroenterol       Date:  2022-09-23       Impact factor: 3.174

Review 7.  Dietary Modification for the Restoration of Gut Microbiome and Management of Symptoms in Irritable Bowel Syndrome.

Authors:  Andrew Thomas; Annie Thomas; Madeline Butler-Sanchez
Journal:  Am J Lifestyle Med       Date:  2021-05-10

8.  Masquerading in the midgut: a rare diagnosis in a patient with recurrent abdominal pain.

Authors:  Philip J Smith; Trusha Patel; Nicholas Reading; Konstantinos Giaslakiotis; Sami Hoque
Journal:  Frontline Gastroenterol       Date:  2019-06-27

9.  The Risk of Osteoporosis and Osteoporotic Fracture Following the Use of Irritable Bowel Syndrome Medical Treatment: An Analysis Using the OMOP CDM Database.

Authors:  Gyu Lee Kim; Yu Hyeon Yi; Hye Rim Hwang; Jinmi Kim; Youngmin Park; Yun Jin Kim; Jeong Gyu Lee; Young Jin Tak; Seung Hun Lee; Sang Yeoup Lee; Youn Hye Cho; Eun Ju Park; Youngin Lee
Journal:  J Clin Med       Date:  2021-05-10       Impact factor: 4.241

10.  Central Sensitization Symptom Severity and Patient-Provider Relationships in a Community Setting.

Authors:  Xiao Jing Wang; Jon O Ebbert; Elizabeth A Gilman; Jordan K Rosedahl; Priya Ramar; Lindsey M Philpot
Journal:  J Prim Care Community Health       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.